CSIR’s anti-cancer drug IIIM-290 goes into clinical trial
The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.